ERICA Study Powerpoint

Below is the PowerPoint presentation given by ERICA.

Open

• The ERICA study is a large randomised controlled cancer trial with 477 practices taking part.

• Aim is to assess the clinical effectiveness of cancer electronic Risk Assessment Tools (eRATs) in diagnosing cancer earlier (stages 1 and 2)

• Comparing the stage of cancers diagnosed in practices using the Skyline cancer tools (intervention) to practices not using eRATs/Skyline (controls)

• Hoping to see a 4-5% increase in the proportion of early-stage cancers diagnosed if the eRATs intervention is successful

• The main trial is now halfway through its 2-year data collection phase (ends March 2024)

The Skyline eRATs:

• 6 cancers: Bladder, Kidney, Lung, Colorectal, Ovarian and Oesophago-gastric

  • Trial is looking at patients 40 and above

  • Generate a pop-up when a patient record is open and if Skyline detects a 2% or greater risk of cancer

  • Calculator has a symptom checker function for exploring possibility of cancer further in consultation with patient

  • New symptoms can be added into the symptom checker, allowing recalculation of the risk of cancer

  • SNOMED codes are generated if new symptoms are ticked

  • The risk score displayed is NOT recorded on a patients record (reference only)

  • Clinicians decide next course of action

  • Skyline works on coded medical records (not free-text)

Risk Scoring

• A risk greater than 5% is considered HIGH (RED)

• A risk score of between 2% and 5% inclusive is considered MODERATE (AMBER)

• A score of less than 2% is considered LOW (NO COLOUR)